Company Overview
- Website
- nomocan.com
- Employees
- 1
- Industry
- Materials/Manufacturing
- SIC Code
-
2834 - Pharmaceutical Preparations
Financials & Stats
Revenue
$3B
Recent News & Media
New gene-editing therapy shows early success in fighting advanced GI cancers
- May 2, 2025
- eurekalert.org
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes
- Dec 30, 2024
- onlinelibrary.wiley.com
Pirfenidone Reduces Epithelial–Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)
- Nov 19, 2024
- pmc.ncbi.nlm.nih.gov
Ketone Bodies Induce Unique Inhibition of Tumor Cell Proliferation and Enhance the Efficacy of Anti-Cancer Agents
- Sep 12, 2023
- pubmed.ncbi.nlm.nih.gov
Tolinapant, a Non-Peptidomimetic Antagonist of Inhibitors of Apoptosis Proteins, cIAP1/2 and XIAP, in Combination with the Hypomethylating Agents, Azacytidine and Decitabine Are Highly Synergistic in in Vitro Models of T Cell Lymphoma
- Nov 15, 2022
- ashpublications.org
The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma
- Nov 15, 2022
- ashpublications.org
Companies Similar to NomoCan Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to NomoCan Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 11 | New York, NY | 2018 | |
| 3M | 2 | Alpharetta, GA | ||
| 3M | 3 | Syracuse, NY | ||
| 3M | 17 | Austin, TX | 1996 | |
| 3M | 5 | New York, NY | 2012 |